OmniComm Systems Signs Five-Year, $8.4 Million Contract With Top-Tier Research Hospital

By GlobeNewswire,  December 01, 2016, 08:00:00 AM EDT


TrialMaster® EDC System Selected to Support Major Medical Research Initiative

FORT LAUDERDALE, Fla., Dec. 01, 2016 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCQX:OMCM), a leading global provider of clinical data management technology, has been selected to provide electronic data capture (EDC) services to a major research hospital in the U.S. Under the terms of a five-year, $8.4 million agreement, the research hospital named OmniComm Systems' TrialMaster® EDC system and related services as the institution's enterprise EDC solution across its entire portfolio of clinical research programs.

The research facility — a major institution seeking to develop cures and treatments for cancer and other catastrophic diseases — selected OmniComm's TrialMaster to standardize clinical development programs and bring greater operational efficiency, speed and quality to the hospital's clinical trials.

"We are honored and humbled to work alongside one of the nation's most prestigious medical research institutes, providing advanced EDC and eSource technology to accelerate their medical research efforts," said Stephen Johnson
, president and chief operating officer at OmniComm. "This contract represents a decisive step for OmniComm in its development of services for integrated EDC. We are extremely pleased to be partnering and working with such a world-class organization."

OmniComm's expertise in integrating electronic medical record (EMR) systems was another important factor in the decision. Data captured in the research hospital's EMR system will automatically import into TrialMaster. This comprehensive eSource solution will help the institution realize the following:

  • Accelerate the process of data capture.
  • Eliminate unnecessary duplication of data.
  • Reduce transcription errors.
  • Enable real-time entry of electronic source data during subject visits.
  • Ensure the accuracy and completeness of data.

The ability to increase productivity and efficiency, while reducing costs, requires the integration of the clinical trial management system (CTMS) and EDC system.  Integrating these systems ensures that shared datapoints are reported correctly in both systems, thereby saving time and reducing the chance for errors. The integration between TrialMaster and the hospital's CTMS will allow the institution to proactively manage activities, such as site initiation, patient recruitment, patient safety, site payments, capacity planning and risk-based monitoring.  OmniComm's OmniConnect™ Web Service API is used to integrate a wide variety of clinical technologies such as CTMS.

OmniComm's TrialMaster EDC was selected for its inherent flexibility, scalability, data quality and broad capabilities to provide a highly configurable, integrated EDC and patient-registry solution.  Specific emphasis for TrialMaster's selection included:

  • Ability to build studies more efficiently and effectively than the hospital's legacy systems.
  • Adeptness in query management workflow.
  • Intuitive interface for all key user groups.
  • Dynamic and centralized monitoring for risk-based monitoring.
  • Ability to export SDTM datasets directly from TrialMaster using Custom Export Utility Tool™.
  • Automated transfer of significant adverse event data using SafetyLink™.
  • Embedded electronic patient recorded outcomes (ePRO).

About OmniComm Systems, Inc.

OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world's pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience, based on more than 5,000 clinical trials. For more information, visit omnicomm.com.

Trademarks

OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.

Contact Info
Dennis Constantinou
OmniComm Systems, Inc. +1.954.473.1254 dconstantinou@omnicomm.com

Source: OmniComm Systems Inc.

This article appears in: News Headlines

Referenced Stocks: OMCM


Latest News Video





Most Active by Volume

Company Last Sale Change Net / %
BAC $ 21.23 0.27 ▼ 1.26%
SIRI $ 4.30 0.26 ▼ 5.60%
CHK $ 7.23 0.18 ▲ 2.55%
P $ 13.33 1.85 ▲ 16.11%
VALE $ 8.44 0.28 ▲ 3.41%
F $ 12.24 0.19 ▼ 1.53%
ABEV $ 4.78 0.02 ▲ 0.42%
WLL $ 12.22 0.14 ▲ 1.16%

As of 12/2/2016, 04:15 PM